批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
| 审批日期 | 提交号 | 审批结论 | 提交分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 1970/06/04 |
ORIG-1(原始申请) |
Approval |
|
UNKNOWN
|
|
|
>>>补充申请<<<
| 审批日期 | 提交号 | 审批结论 | 补充类别或审批类型 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2025/07/03 |
SUPPL-41(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2017/04/14 |
SUPPL-33(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs. |
| 2013/03/07 |
SUPPL-30(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2009/05/13 |
SUPPL-26(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2006/01/12 |
SUPPL-24(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2002/12/20 |
SUPPL-23(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2001/09/28 |
SUPPL-22(补充) |
Approval |
Manufacturing (CMC)-Control |
|
|
|
| 1999/11/26 |
SUPPL-21(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 1994/04/28 |
SUPPL-20(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
| 1985/12/10 |
SUPPL-4(补充) |
Approval |
Manufacturing (CMC)-Control |
|
|
|
| 1983/04/11 |
SUPPL-3(补充) |
Approval |
Manufacturing (CMC)-Expiration Date |
|
|
|
| 1983/03/14 |
SUPPL-2(补充) |
Approval |
Manufacturing (CMC)-Expiration Date |
|
|
|
| 1982/10/07 |
SUPPL-1(补充) |
Approval |
Labeling |
|
|
|
| 1981/10/23 |
SUPPL-19(补充) |
Approval |
Manufacturing (CMC)-Control |
|
|
|
| 1980/08/18 |
SUPPL-18(补充) |
Approval |
Labeling |
|
|
|
| 1980/01/18 |
SUPPL-17(补充) |
Approval |
Manufacturing (CMC)-Expiration Date |
|
|
|
| 1979/08/31 |
SUPPL-16(补充) |
Approval |
Labeling |
|
|
|
| 1978/12/08 |
SUPPL-15(补充) |
Approval |
Manufacturing (CMC)-Control |
|
|
|
| 1976/05/17 |
SUPPL-14(补充) |
Approval |
Manufacturing (CMC)-Control |
|
|
|
| 1975/09/11 |
SUPPL-13(补充) |
Approval |
Manufacturing (CMC)-Control |
|
|
|
| 1973/12/14 |
SUPPL-12(补充) |
Approval |
Manufacturing (CMC)-Control |
|
|
|
| 1972/06/05 |
SUPPL-9(补充) |
Approval |
Manufacturing (CMC)-Control |
|
|
|
| 1971/02/11 |
SUPPL-8(补充) |
Approval |
Labeling |
|
|
|
| 1970/12/22 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC)-Control |
|
|
|
| 1970/12/19 |
SUPPL-7(补充) |
Approval |
Labeling |
|
|
|
| 1970/08/17 |
SUPPL-5(补充) |
Approval |
Manufacturing (CMC)-Control |
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
| 关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
| 无 |
与本品治疗等效的药品
>>>活性成分:COLISTIMETHATE SODIUM; 剂型/给药途径:INJECTABLE;INJECTION; 规格:EQ 150MG BASE/VIAL; 治疗等效代码:AP<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 050108 |
002 |
NDA |
COLY-MYCIN M |
COLISTIMETHATE SODIUM |
INJECTABLE;INJECTION |
EQ 150MG BASE/VIAL |
Prescription |
Yes |
Yes |
AP |
Approved Prior to Jan 1, 1982
|
PH HEALTH |
| 064216 |
001 |
ANDA |
COLISTIMETHATE SODIUM |
COLISTIMETHATE SODIUM |
INJECTABLE;INJECTION |
EQ 150MG BASE/VIAL |
Discontinued |
No |
No |
AP |
1999/02/26
|
PHARMOBEDIENT |
| 065177 |
001 |
ANDA |
COLISTIMETHATE SODIUM |
COLISTIMETHATE SODIUM |
INJECTABLE;INJECTION |
EQ 150MG BASE/VIAL |
Discontinued |
No |
No |
AP |
2004/03/19
|
NEXUS |
| 065364 |
001 |
ANDA |
COLISTIMETHATE SODIUM |
COLISTIMETHATE SODIUM |
INJECTABLE;INJECTION |
EQ 150MG BASE/VIAL |
Prescription |
No |
No |
AP |
2008/04/17
|
FRESENIUS KABI USA |
| 202359 |
001 |
ANDA |
COLISTIMETHATE SODIUM |
COLISTIMETHATE SODIUM |
INJECTABLE;INJECTION |
EQ 150MG BASE/VIAL |
Prescription |
No |
No |
AP |
2012/09/28
|
AVET LIFESCIENCES |
| 201365 |
001 |
ANDA |
COLISTIMETHATE SODIUM |
COLISTIMETHATE SODIUM |
INJECTABLE;INJECTION |
EQ 150MG BASE/VIAL |
Prescription |
No |
No |
AP |
2014/02/19
|
SAGENT PHARMS INC |
| 205356 |
001 |
ANDA |
COLISTIMETHATE SODIUM |
COLISTIMETHATE SODIUM |
INJECTABLE;INJECTION |
EQ 150MG BASE/VIAL |
Prescription |
No |
No |
AP |
2015/05/29
|
XELLIA PHARMS APS |